Sems

The barcode 8692359005519 is associated with a product labeled as "SEMS" (likely referring to Self-Expanding Metal Stents), a type of medical device used primarily in vascular or biliary interventions. Below is a detailed breakdown based on available data and industry standards:

Product Identification & Classification

1. Product Type:

   • Self-Expanding Metal Stent (SEMS) – Typically used in:
     • Coronary arteries (for treating blockages in heart blood vessels).
     • Biliary tract (for bile duct obstructions, e.g., due to cancer or gallstones).
     • Esophagus (for strictures or tumors).
     • Trachea/bronchi (rarely, for airway obstruction).
   • The exact application depends on the manufacturer’s specifications (not directly derivable from the barcode alone).

2. Manufacturer/Origin:

   • The barcode prefix 8692359 suggests the product is distributed in China (country code 86) and may be manufactured by a Chinese or international company with a Chinese distributor.
   • Common brands producing SEMS include Boston Scientific, Medtronic, Cook Medical, or Chinese manufacturers like Micro-Tech (MTN). However, 8692359005519 does not uniquely identify a specific brand without additional context (e.g., packaging or documentation).

3. Regulatory Status:

   • In the U.S., SEMS are classified as Class II medical devices under the FDA, requiring premarket approval (PMA) or 510(k) clearance for coronary/biliary stents.
   • In the EU, they fall under MDD/IVDR regulations (Medical Device Directives).
   • China: Regulated by the NMPA (National Medical Products Administration) under Class III (high-risk) devices.
   • Warnings/Concerns:
     • Counterfeit Risk: SEMS are high-value devices prone to counterfeiting. Fake stents may fail structurally, leading to perforations, migrations, or thrombosis (e.g., coronary stents causing heart attacks).
     • Material Compatibility: Some SEMS use cobalt-chromium or stainless steel alloys, which may cause allergic reactions in sensitive patients.
     • Recall History: Older or poorly manufactured stents have been recalled for premature closure, excessive expansion, or drug elution issues (if drug-eluting).
     • Biliary Stents: May require periodic replacement (e.g., every 3–6 months) due to clogging; improper placement can cause cholangitis (bile duct infection).
     • Coronary Stents: Drug-eluting stents (DES) carry risks of late stent thrombosis or in-stent restenosis (narrowing).